LY3437943
DrugAdministered SC
NCT Number: NCT06313528
The main purpose of the study is to look at the effect of the study drug compared to placebo on calorie intake, energy metabolism, and appetite. The study will last up to 6 months and may include up to 20 visits.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 1
AdventHealth Orlando, Orlando, Florida, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administered SC
Administered SC
Time frame: Baseline up to Week 17 (inclusive)
Time frame: Baseline up to Week 16 (inclusive)
In participants who achieve target weight loss
Time frame: Baseline up to Week 16 (inclusive)
Time frame: Baseline up to Week 16 (inclusive)
In participants who achieve target weight loss
Time frame: Baseline up to Week 16 (inclusive)
Time frame: Baseline up to Week 17 (inclusive)
Time frame: Baseline up to Week 17 (inclusive)
Time frame: Baseline up to Week 16 (inclusive)
Eli Lilly and Company
Industry
A Randomized, Double-Blind, Phase 1 Study to Investigate the Effect of LY3437943 Versus Placebo on Calorie Intake and Energy Expenditure in Participants With Obesity Under Calorie Restriction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial Details